ADA and Stroke: The main clinical indications included acute lymphoblastic leukaemia, Parkinson's disease, haemophilia, defects of the bladder, knee cartilage lesions, adenosine deaminase deficiency, melanoma, stroke, multiple sclerosis and retinal disease.